Fundraising Fox
🦊/Companies
Sign in

PneumaCare

Cambridge, GB · 2 known investors

Find your way into PneumaCare

PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings. The company serves clinicians assessing respiratory conditions such as COPD, with a UK/Cambridge base.

Digital HealthHealthtechMedical Devices

Founders & leadership

BABart A. Lewin
Bart A. LewininChief Executive Officer

Investors · 2

Cambridge Angels groupCambridge · $195K – $1.9M
Cambridge Capital GroupreportedCambridge

In the news

PneumaCare on track to meet funding target | Insider Mediainsidermedia.com · Oct 2014PneumaCare Announces Completion of £1M Financing and New Board Appointment - BioSpacebiospace.com · Oct 2013New financing round for PneumaCare – Cambridge Enterpriseenterprise.cam.ac.uk · Aug 2011lung | University of Cambridgecam.ac.uk

Frequently asked questions

What does PneumaCare do?
PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings. The company serves clinicians assessing respiratory conditions such as COPD, with a UK/Cambridge base.
Who are PneumaCare's investors?
PneumaCare's investors include Cambridge Angels group, Cambridge Capital Group.
Where is PneumaCare headquartered?
PneumaCare is headquartered in Cambridge, GB.